Vertex Pharmaceuticals
VRTX
#178
Rank
NZ$203.13 B
Marketcap
NZ$792.28
Share price
1.97%
Change (1 day)
12.23%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2025 (TTM): NZ$7.67 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are NZ$11.72 Billion. In 2024 the company made an earning of NZ$0.48 Billion a decrease over its 2023 earnings that were of NZ$7.68 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$7.67 B1482.8%
2024 NZ$0.48 B-93.69%
2023 NZ$7.68 B3.19%
2022 NZ$7.44 B53.56%
2021 NZ$4.84 B-12.06%
2020 NZ$5.51 B118.45%
2019 NZ$2.52 B120.64%
2018 NZ$1.14 B1473.64%
2017 NZ$72.7 M197.6%
2016 NZ$24.42 M-102.97%
2015 -NZ$0.83 Billion-28.46%
2014 -NZ$1.15 Billion-51.5%
2013 -NZ$2.38 Billion-30584.68%
2012 NZ$7.77 M-95.47%
2011 NZ$0.17 B
2009 -NZ$1.03 Billion
2007 -NZ$0.72 Billion83.1%
2006 -NZ$0.4 Billion59.02%
2005 -NZ$0.25 Billion3.28%
2004 -NZ$0.24 Billion-38.16%
2003 -NZ$0.39 Billion
2000 -NZ$66.07 Million-20.38%
1999 -NZ$82.98 Million31.62%
1998 -NZ$63.05 Million91.05%
1997 -NZ$33 Million-36.24%
1996 -NZ$51.76 Million12.45%
1995 -NZ$46.03 Million27.4%
1994 -NZ$36.13 Million-1833.33%
1993 NZ$2.08 M-112.12%
1992 -NZ$17.2 Million175%
1991 -NZ$6.26 Million-12.2%
1990 -NZ$7.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
NZ$17.16 B 121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$2.88 B-62.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$40.10 B 417.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.95 B 80.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$56.26 B 626.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-NZ$0.14 Billion-101.70%๐Ÿ‡บ๐Ÿ‡ธ USA